Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Aarkstore enterprise---Anti-Infective Drugs Markets

Posted Oct 26 2010 6:13am

Six infectious diseases - pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS - account for half of all premature deaths worldwide, killing mostly children and young adults, according to the World Health Organization (WHO). Moreover, threatening
pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world.

This report analyzes the anti-infective drugs market and highlights the existing and developing anti-infectives used to ameliorate infectious diseases' afflictions on humankind. Anti-infective drugs include.
anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Particular attention is paid to the clinical market segment and the pharmaceutical/biotechnology companies involved in anti-infective drugs with specific emphasis on each company's sales focus, product portfolio and R&D pipeline.

To date, the most successful anti-infective drugs target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitis C (HCV). A number of exciting novel anti-viral and antibiotic compounds are currently revolutionizing anti-infective drugs markets, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapies, respectively. Significant resources are also being dedicated toward hepatitis A (HAV), hepatitis B (HBV) and Staph infections, including MRSA.

What's more, this study will examine the existing and developing anti-infective drugs targeted at infectious diseases that continue to devastate developing countries, including: cholera, dengue fever, meningitis, rotavirus, typhoid and yellow fever.


Key Topics Covered:

- Overview
- Clinical Syndromes and Therapy
- Anti-Infective Drugs Market
- Description of Anti-Infective Therapeutic Agents
- Market for Anti-Infective Drugs and Vaccines
- Decision-making Activity in the Anti-Infective Drugs Market
- Economics of Anti-Microbial Drug Resistance: The Persistent Need for Anti-Bacterials
- Global Market Analysis of Anti-Infective Drugs
- Global Market for Anti-Bacterial Therapies
- Global Market for Anti-Fungal Therapies
- Global Market for Anti-Viral Therapies
- Market, Demographic and Economic Trends
- Political/Legal Trends
- Technological Trends
- Socio-Cultural Trends
- Competitive Landscape
- Sales Performance amongst the Leading Players: Detailed Analysis of Leading Anti-Infective Players
- Company Profiles

Companies Mentioned.

- Adlyfe, Inc.


- Advanced Life Sciences Holdings, Inc.


- Affinium Pharmaceuticals
- APP Pharmaceuticals
- Aquapharm Biodiscovery
- Basilea Pharmaceutica AG
- Biophage Pharma, Inc.


- CEL-SCI Corporation
- Cerexa, Inc. (Subsidiary of Forest Laboratories)
- Daiichi Sankyo Co., Ltd.


- Hospira, Inc.


- Incyte Corporation
- Idenix Pharmaceuticals, Inc.


- Medivir AB
- Mutabilis
- NanoBio Corporation
- Nanosphere, Inc.


- Novabay Pharmaceuticals, Inc.


- Obetech, LLC
- Optimer Pharmaceuticals, Inc.


- Panacos Pharmaceuticals, Inc.


- Paratek Pharmaceuticals, Inc.


- Pharmasset, Inc.


- Ribomed Biotechnologies, Inc.


For more information please contact :

http://www.aarkstore.com/reports/Anti-Infective-Drugs-Markets-66396.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com

Post a comment
Write a comment:

Related Searches